Renewable Energy Interconnected Power System Load Frequency Control Under Network Attacks and Communication Time Delay by MI Yang, YANG Zishuai, XU Mingming, ZHOU Jie, HAN Yunhao

Subjects: “…renewable energy interconnected power system|network attacks|communication time delay|event triggering|sliding mode load frequency control…”
Get full text

Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report by Tomoyuki Otsuka, Yoshiki Kojitani, Fumio Imamura, Junko Fukutake, Minako Nishio, Takashi Fujii, Toshihiro Kudo

Subjects: “…immune-related adverse event…”
Get full text

The prognostic association of triglyceride-glucose index and its derived indicators with stable coronary artery disease patients undergoing percutaneous coronary intervention by Yu Shan, Yu Shan, Maoning Lin, Maoning Lin, Fangfang Gu, Duanbin Li, Duanbin Li, Qiongjun Zhu, Qiongjun Zhu, Zhezhe Chen, Zhezhe Chen, Wenbin Zhang, Wenbin Zhang, Guosheng Fu, Guosheng Fu, Min Wang, Min Wang

Subjects: “…major adverse cardiovascular and cerebrovascular events…”
Get full text

DLP: REDUCED RISK OF LEAKAGE OF CONFIDENTIAL INFORMATION OF THE BANK by T. A. Andryianava, S. B. Salomatin

Subjects: “…an information security event…”
Get full text

Time perspective and significance of life events in adolescence by N. P. Shilova, A. K. Vladyko

Subjects: “…adolescence, life events, time perspective, early adolescence, late adolescence, «emerging adulthood», present, future, vocational training, professional autonomy…”
Get full text

Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study by Shan Huang, Lu-Jiao Yu, Guang-Feng Sun, Zi-Xin Zhang

Subjects: “…Major adverse cardiac events…”
Get full text

Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system by Yixuan Yang, Hanzhang Xie, Shuhan Liu, Ying Jia, Bingnan Cui, Zhanshuo Xiao

Subjects: Get full text

Case report: Multi-organ injuries induced by tislelizumab by Man Yuan, Man Yuan, Ning Han, Ning Han, Li Shu, Libo Yan, Libo Yan, Hong Tang, Hong Tang

Subjects: “…immune-related adverse events…”
Get full text

Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study by Ping Zhou, Bing Liu, Ning Shen, Xiaoting Fan, Shangwei Lu, Zhijuan Kong, Ying Gao, Zhimei Lv, Rong Wang

Subjects: “…immune-related adverse events…”
Get full text

Increased indexed proximal aortic diameter is a predictor of poor prognosis in maintenance hemodialysis patients by Junwei Xu, Wenyi Tang, Lizheng Song, Yuxi Huang, Li Xiao, Fangyuan Cheng, Qianglin Guan, Mei Xu, Chuoxin Ma, Jian Chen, Jianting Ke

Subjects: “…major adverse cardiovascular events…”
Get full text

Development of the congress and exhibition industry in the Russian Federation by E. N. Dunenkova, M. I. Isayeva

Subjects: Get full text

The possibility of applying calculation based on queuing theory with the aim of real-time control by V. I. Kudriavtsev, О. F. Zirko

Subjects: Get full text

Specificity of the operator’s activity performing the work with the forecasting tools of technologically and chronologically interconnected events in the system of continuous forec... by V. V. Savluchinskij

Subjects: Get full text

An overview of the transboundary dust events in southeastern Turkmenistan near the border of Iran (Sarakhs-Badkhyz region) by Mohammad Reza Mansouri Daneshvar, Seyed Javad Rasouli, Aliasghar Dehqanpour Aliaqa

Subjects: “…Transboundary dust event…”
Get full text

Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis by Arthur Mader, Dario Haeberli, Barbara Larcher, Jörn F. Dopheide, Christoph H. Saely, Christine F. Heinzle, Peter Amann, Marc Schindewolf, Andreas Festa, Heinz Drexel

Subjects: “…Major adverse cardiovascular events…”
Get full text

SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP by Alessandro Laganà, Giovanni Manfredi Assanto, Chiara Masucci, Mauro Passucci, Livia Donzelli, Alessandra Serrao, Erminia Baldacci, Cristina Santoro, Antonio Chistolini

Subjects: Get full text

Finansal Piyasalarda Seçili Yatırım Araçlarının Rusya-Ukrayna Savaşına Tepkisinin Olay Çalışması Yaklaşımı ile İncelenmesi by Vedat Sarıkovanlık, Gizem Arı, Mahammad Charkasov

Subjects: Get full text

Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database by Shuai Zhao, Yan Wang, Xiaoli Deng, Xi Chen, Zhaoyi Lu

Subjects: Get full text

IDS Transposer: A Users Guide by Emily Klancher Merchant, George Alter

Subjects: Get full text